Sarda Proteins Intrinsic Value
SRDAPRT Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹13.11 | ₹11.80 - ₹14.42 | -80.0% | Book Value/Share: ₹6.67, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹42.67 | ₹38.40 - ₹46.94 | -34.9% | Revenue/Share: ₹53.33, P/S: 0.8x |
Want to compare with current market value? Check SRDAPRT share price latest .
Valuation Comparison Chart
SRDAPRT Intrinsic Value Analysis
What is the intrinsic value of SRDAPRT?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Sarda Proteins (SRDAPRT) is ₹42.67 (median value). With the current market price of ₹65.55, this represents a -34.9% variance from our estimated fair value.
The valuation range spans from ₹13.11 to ₹42.67, indicating ₹13.11 - ₹42.67.
Is SRDAPRT undervalued or overvalued?
Based on our multi-method analysis, Sarda Proteins (SRDAPRT) appears to be trading above calculated value by approximately 34.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | -11.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 5.33x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Sarda Proteins
Additional stock information and data for SRDAPRT
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |